Scotia Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-13,704
Closed -$432K – 835
2023
Q4
$432K Buy
13,704
+1,808
+15% +$49.1K ﹤0.01% 608
2023
Q3
$334K Buy
11,896
+2,486
+26% +$85.4K ﹤0.01% 621
2023
Q2
$347K Buy
+9,410
New +$287K ﹤0.01% 610
2018
Q1
– Sell
-13,098
Closed -$655K – 707
2017
Q4
$655K Hold
13,098
– – 0.01% 482
2017
Q3
$662K Buy
13,098
+4,467
+52% +$211K 0.01% 474
2017
Q2
$328K Buy
8,631
+1,500
+21% +$59.2K 0.01% 552
2017
Q1
$275K Buy
+7,131
New +$215K ﹤0.01% 618

Other funds holding CC

Scotia Capital's CC Position: Q1 2024 in Review

Scotia Capital sold out of Chemours (CC) in Q1 2024, closing a stake of 13,704 shares — an estimated $432K sold.

Scotia Capital first reported a position in CC in Q1 2017 and held it in 7 quarters. The position peaked at $662K in Q3 2017. 444 funds tracked by Wall St. Rank hold CC as of Q1 2024.

  • Scotia Capital reported no remaining Chemours position as of Q1 2024 after selling out during the quarter.
  • Scotia Capital sold 13,704 Chemours shares in Q1 2024, an estimated $432K.
  • Scotia Capital first reported a position in Chemours in Q1 2017 and held it in 7 quarters.
  • Scotia Capital's Chemours position peaked at $662K in Q3 2017.
  • 444 funds tracked by Wall St. Rank held Chemours as of Q1 2024.

Based on Scotia Capital's 13F filing for Q1 2024, filed 14 May 2024.